Amyris Biotechnologies (Emeryville, CA) a development-stage biofuels company focused on metabolic pathway transformations of plant-based feedstocks into different isoprenoids, closed a $24.8M Series C financing. Participants include Khosla Ventures, Kleiner Perkins Caufield & Byers, DAG Ventures and TPGBiotech.